Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.092 AUD | -1.08% | +1.10% | -16.36% |
22/04 | Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data | MT |
22/04 | PYC Therapeutics Confirms Safety, Tolerability of Kidney Medication in Animal Study | MT |
Sales 2024 * | 8M 5.23M 436M | Sales 2025 * | 8M 5.23M 436M | Capitalization | 411M 269M 22.41B |
---|---|---|---|---|---|
Net income 2024 * | -31M -20.25M -1.69B | Net income 2025 * | -34M -22.21M -1.85B | EV / Sales 2024 * | 46.3 x |
Net cash position 2024 * | 40.79M 26.65M 2.22B | Net cash position 2025 * | 75.26M 49.16M 4.1B | EV / Sales 2025 * | 42 x |
P/E ratio 2024 * |
-11.6
x | P/E ratio 2025 * |
-12.1
x | Employees | 5 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.44% |
Latest transcript on PYC Therapeutics Limited
1 day | -1.08% | ||
1 week | +1.10% | ||
Current month | +12.20% | ||
1 month | +10.84% | ||
3 months | +9.52% | ||
6 months | +55.93% | ||
Current year | -16.36% |
Managers | Title | Age | Since |
---|---|---|---|
Rohan Hockings
CEO | Chief Executive Officer | 40 | - |
Andrew Taylor
DFI | Director of Finance/CFO | - | - |
Kevin Hart
DFI | Director of Finance/CFO | 62 | 24/17/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 17/21/17 | |
Jason Haddock
BRD | Director/Board Member | 54 | 29/21/29 |
Alan W. Tribe
CHM | Chairman | 76 | 11/18/11 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.092 | -1.08% | 437,537 |
24/24/24 | 0.093 | -1.06% | 564,511 |
23/24/23 | 0.094 | +4.44% | 747,972 |
22/24/22 | 0.09 | -1.10% | 5,146,687 |
19/24/19 | 0.091 | -4.21% | 2,313,899 |
Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.36% | 268M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PYC Stock